EG-Pancreatic Blood Test-E1
EG-Pancreatic Blood Test-E1 is an innovative, non-invasive early detection tool for pancreatic cancer. Using DNA methylation technology, it only requires 8 milliliters of blood to assess early cancer risk, enabling earlier detection and timely treatment to improve outcomes and survival rates.
Who Needs This Test?
-
Diabetic patients (leading to pancreatic dysfunction)
-
Those with a history of pancreatic cancer
-
Patients with chronic pancreatitis
-
Individuals with a family history of pancreatic cancer (such as mutations in BRCA1, BRCA2, or PALB2 genes)
-
Those with abnormal tumor markers (such as elevated CA19-9 levels)
Download the flyer for more information.
Non-invasive testing requiring only blood sample.
Testing can be performed anytime, without limitations on timing or frequency.
A New Approach to Early Pancreatic Cancer Diagnosis
Pancreatic cancer often has no symptoms early on and is mistaken for common issues like fatigue or loss of appetite, leading many patients to miss the best treatment window.
Using DNA methylation technology, this non-invasive test enables early detection, providing valuable treatment time and improving survival rates and quality of life.
Specimen Collection Instructions
Sample type:
-
Whole blood specimens collected in Cell-Free DNA BCT® tubes.
Sample Requirement:
-
No fasting required prior to blood collection.
-
A minimum volume of 8 mL is required.
-
Specimens must be non-coagulated.
-
Mix the blood collection tube thoroughly after sampling, as shown below
Storage and Transportation:
-
Store and transport specimens in Cell-Free DNA BCT® tubes at room temperature.
-
Do not freeze.
-
Specimens are stable for up to 6 days at room temperature and must be delivered within this period
Turnaround Time (TAT):
-
7 Business Days (Mon-Fri)
